Get the Stockscreener App
111.39
3.19%
3.44
After Hours:
111.40
0.01
+0.01%
Vaneck Pharmaceutical Etf stock is traded at $111.39, with a volume of 469.43K.
It is up +3.19% in the last 24 hours and up +10.05% over the past month.
See More
Previous Close:
$107.95
Open:
$109.4
24h Volume:
469.43K
Relative Volume:
1.70
Market Cap:
$907.13M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.29%
1M Performance:
+10.05%
6M Performance:
+7.39%
1Y Performance:
+26.04%
1-Day Range:
$108.98
$111.72
1-Week Range:
$106.79
$111.72
52-Week Range:
$81.74
$112.58
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Name
Vaneck Pharmaceutical Etf
Sector
Industry
Phone
-
Address
-
Compare PPH vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
111.39 | 907.13M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
368.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
744.78 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
748.43 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.34 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
712.60 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Stock (PPH) Latest News
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.6248 - MSN
Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy? - AOL.com
Choosing Between VHT and PPH ETFs for Medical Sector Portfolios - HarianBasis.co
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - The Globe and Mail
Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns. - AOL.com
Should you invest in the VanEck pharmaceutical ETF (PPH)? - MSN
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
FHLC vs PPH: Choosing Between Broad Healthcare and Targeted Pharmaceuticals - sekbernews.id
PPH vs IXJ: Targeted Pharma ETF vs Broad Healthcare ETF — A Performance and Cost ComparisonDividend Growth Analysis - The Legal Advocate
PPH vs IXJ ETF Comparison: Pure Pharma vs Holistic Healthcare ExposureRevenue Growth Outlook - The Legal Advocate
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem - AOL.com
IHEiShares U.S. Pharmaceuticals ETF Stock Price and Quote - Finviz
PPH Stock Price, Quote & Chart | VANECK PHARMACEUTICAL ETF (NASDAQ:PPH) - ChartMill
Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery - Benzinga
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
VanEck Launches WARP ETF for Access to Rapidly Expanding Space Economy - MEXC
7 ETFs to Play a Healthcare Rebound - Barron's
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - MSN
Introducing the VanEck Vectors Pharmaceutical ETF - Stock Investor
What's Going On With Merck Stock Tuesday? - Benzinga
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.8441 - MSN
VanEck Biotech ETF (BBH) stock price, news, quote and history - Yahoo Finance Singapore
VanEck Pharmaceutical ETF (PPHus) Stock Price Quote Today & Current Price Chart - Capital.com
VanEck ETF TrustVanEck Pharmaceutical ETF announces Quarterly dividend, payable on April 07, 2026 - MarketScreener
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move - TradingView — Track All Markets
Pharma Stocks Pfizer, GSK Offer Defensive Plays in an Uncertain Market: Charts - Barron's
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 - AOL.com
VEFV ETF Analysis: Dividends, Returns MUN:VEFV - tradingview.com
VEFV ETF Holdings List — MUN:VEFV - TradingView
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - TradingView
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
Vaneck Pharmaceutical Etf Stock (PPH) Financials Data
There is no financial data for Vaneck Pharmaceutical Etf (PPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.82%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):